As of 2025-11-13, the Relative Valuation of BB Biotech AG (BION.SW) is 59.93 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 41.45 CHF, the upside of BB Biotech AG based on Relative Valuation is 44.6%.
The range of the Relative Valuation is 43.60 - 96.18 CHF.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 32.1x | 24.0x |
| Forward P/E multiples | 12.6x - 19.1x | 13.8x |
| Fair Price | 43.60 - 96.18 | 59.93 |
| Upside | 5.2% - 132.0% | 44.6% |
| Date | P/E |
| 2025-11-11 | 13.71 |
| 2025-11-10 | 13.59 |
| 2025-11-07 | 13.37 |
| 2025-11-06 | 13.62 |
| 2025-11-05 | 13.59 |
| 2025-11-04 | 13.69 |
| 2025-11-03 | 13.59 |
| 2025-10-31 | 13.71 |
| 2025-10-30 | 13.76 |
| 2025-10-29 | 13.64 |
| 2025-10-28 | 13.57 |
| 2025-10-27 | 13.69 |
| 2025-10-24 | 13.27 |
| 2025-10-23 | 12.76 |
| 2025-10-22 | 12.99 |
| 2025-10-21 | 13.02 |
| 2025-10-20 | 13.01 |
| 2025-10-17 | 12.82 |
| 2025-10-16 | 12.92 |
| 2025-10-15 | 12.81 |
| 2025-10-14 | 12.71 |
| 2025-10-13 | 12.72 |
| 2025-10-10 | 12.74 |
| 2025-10-09 | 13.01 |
| 2025-10-08 | 13.16 |
| 2025-10-07 | 12.99 |
| 2025-10-06 | 12.62 |
| 2025-10-03 | 12.46 |
| 2025-10-02 | 12.22 |
| 2025-10-01 | 12.32 |
| 2025-09-30 | 12.09 |
| 2025-09-29 | 12.06 |
| 2025-09-26 | 11.81 |
| 2025-09-25 | 12.02 |
| 2025-09-24 | 12.19 |
| 2025-09-23 | 12.29 |
| 2025-09-22 | 12.31 |
| 2025-09-19 | 12.14 |
| 2025-09-18 | 11.87 |
| 2025-09-17 | 11.92 |
| 2025-09-16 | 11.76 |
| 2025-09-15 | 11.64 |
| 2025-09-12 | 11.76 |
| 2025-09-11 | 11.76 |
| 2025-09-10 | 11.62 |
| 2025-09-09 | 11.52 |
| 2025-09-08 | 11.26 |
| 2025-09-05 | 11.42 |
| 2025-09-04 | 11.32 |
| 2025-09-03 | 11.42 |